Aulisa® Medical USA Launches Flexible Leasing Options for Advanced Continuous Vital Sign Monitoring Solutions

08 November 2024 | Friday | News

New leasing plans make Aulisa's FDA-cleared Guardian Angel® monitoring systems more accessible to healthcare providers, empowering facilities to deliver high-quality, efficient care while managing costs and maintaining access to cutting-edge technology.
Picture Courtesy | Public Domain

Picture Courtesy | Public Domain

Aulisa® Medical USA, Inc., a leader in FDA-cleared, wearable, wireless continuous vital sign monitoring technology, proudly announces the launch of flexible leasing options for its state-of-the-art monitoring solutions. This strategic move underscores Aulisa's mission to bring the latest in healthcare technology to more providers and settings, ensuring that patient care remains efficient, effective, and accessible.

healthcare landscape, staying at the forefront of medical technology is essential for providing high-quality patient care. Yet, budget constraints and high upfront costs can make this challenging for many hospitals, clinics, and specialized care facilities. Aulisa's new leasing plans are designed to provide easy and flexible financing alternatives for healthcare facilities to acquire advanced Aulisa® Guardian Angel monitoring solutions without financial strain. By offering these options, Aulisa helps providers maintain optimal care standards while managing expenses more efficiently.

"Offering leasing options is a natural extension of our commitment to enhancing patient safety and supporting healthcare professionals," said Augustine (Augie) Lien, founder and CEO of Aulisa Medical USA, Inc. "We want to remove the barriers that prevent facilities from accessing the tools they need to deliver exceptional care. By easing financial constraints, we empower providers to stay equipped with cutting-edge technology that can make a real difference in patient outcomes."

Comprehensive Monitoring Solutions for Every Patient-care Setting
Aulisa's Guardian Angel® CMPM (Centralized Multiple Patient Monitoring) System has set a high standard in patient monitoring by delivering real-time data on oxygen saturation (SpO2), pulse rate (PR), and body temperature. Now available with flexible leasing options, this system provides unparalleled support to healthcare professionals who need to monitor multiple patients simultaneously, improving workflow efficiency and responsiveness in critical care settings like ICUs and NICUs.

Key Advantages of Leasing Equipment for Healthcare Facilities
Leasing Aulisa's advanced monitoring systems presents numerous advantages that resonate with the needs of healthcare facilities. Monthly leasing plans allow institutions to allocate funds more efficiently by spreading out costs, avoiding significant upfront expenditures. This model provides financial predictability, as fixed rates prevent budget surprises and enable better long-term planning. Additionally, leasing offers the flexibility to upgrade equipment during the lease term, ensuring that facilities continue to benefit from the latest advancements without the burden of repurchasing.

The immediate access to new technology that leasing offers can enhance patient care significantly. Facilities can implement state-of-the-art monitoring systems quickly, supporting faster and more informed decision-making in patient treatment. Leasing also provides potential tax benefits, as lease payments may be deductible and can improve cash flow by preserving existing lines of credit for other critical investments.

Commitment to Innovation and Accessibility
Aulisa's introduction of leasing options reaffirms its dedication to innovation and the accessibility of critical monitoring technology. From hospital ICUs and NICUs to specialized clinical settings, Aulisa's FDA-cleared solutions are designed to ensure reliable, high-quality patient monitoring that healthcare providers can trust.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close